• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

c-myc和bcl-2在原发性及晚期皮肤黑色素瘤中的表达

Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma.

作者信息

Utikal Jochen, Leiter Ulrike, Udart Martin, Kaskel Peter, Peter Ralf Uwe, Krähn Gertraud M

机构信息

Department of Dermatology, University Hospital of Mannheim, Ruprecht-Karls University, Heidelberg, 68135 Mannheim, Germany.

出版信息

Cancer Invest. 2002;20(7-8):914-21. doi: 10.1081/cnv-120005904.

DOI:10.1081/cnv-120005904
PMID:12449722
Abstract

Apoptosis is an important co-factor in the pathogenesis of a plethora of malignancies. Enhanced c-myc activation can result either in proliferation or apoptosis. Coexpression with antiapoptotic bcl-2, which abrogates the apoptotic function of c-myc might lead to an enormous growth advantage of cells. In order to elucidate the role of c-myc and bcl-2 as well as the coexpression of both genes in human melanoma, their expression was studied in four samples of normal skin (SK), 15 surgical margins (SM), 20 benign melanocytic nevi (MN), 20 primary melanomas (MM), and 30 melanoma metastases (MMET) by RT-PCR. These results were compared with immunohistochemistry (IH) in 7 SK, 7 SM, 26 MN, 50 MM, and 34 MMET. Similar results were found with both methods. However, MMET expressed c-myc (PCR 28/30, IH 23/34) as well as bcl-2 (PCR 27/30, IH 24/34) more frequently. Primary melanomas showed a similar expression pattern as SM and nevi. Moreover, in contrast to SK, SM, MN, and MM coexpression of bcl-2 and c-myc was found more frequently in MMET (PCR 25/30, p < 0.01, IH 19/34, p < 0.01). These results indicate that coexpression of c-myc and bcl-2 appears to be associated with advanced melanoma and contributes to the malignant phenotype.

摘要

细胞凋亡是众多恶性肿瘤发病机制中的一个重要辅助因素。增强的c-myc激活可导致增殖或细胞凋亡。与抗凋亡的bcl-2共表达可消除c-myc的凋亡功能,这可能导致细胞具有巨大的生长优势。为了阐明c-myc和bcl-2的作用以及这两个基因在人类黑色素瘤中的共表达情况,通过逆转录聚合酶链反应(RT-PCR)对4份正常皮肤样本(SK)、15份手术切缘样本(SM)、20份良性黑素细胞痣样本(MN)、20份原发性黑色素瘤样本(MM)和30份黑色素瘤转移样本(MMET)进行了它们的表达研究。并将这些结果与7份SK、7份SM、26份MN、50份MM和34份MMET样本的免疫组织化学(IH)结果进行了比较。两种方法得到了相似的结果。然而,MMET更频繁地表达c-myc(PCR检测为28/30,IH检测为23/34)以及bcl-2(PCR检测为27/30,IH检测为24/34)。原发性黑色素瘤显示出与SM和痣相似的表达模式。此外,与SK、SM、MN和MM不同的是,在MMET中更频繁地发现bcl-2和c-myc的共表达(PCR检测为25/30,p<0.01;IH检测为19/34,p<0.01)。这些结果表明,c-myc和bcl-2的共表达似乎与晚期黑色素瘤相关,并有助于恶性表型的形成。

相似文献

1
Expression of c-myc and bcl-2 in primary and advanced cutaneous melanoma.c-myc和bcl-2在原发性及晚期皮肤黑色素瘤中的表达
Cancer Invest. 2002;20(7-8):914-21. doi: 10.1081/cnv-120005904.
2
Antiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma.晚期恶性黑色素瘤中的抗凋亡蛋白bcl-2和bcl-xL
Arch Dermatol Res. 2000 May;292(5):225-32. doi: 10.1007/s004030050479.
3
Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients.黑色素瘤患者前哨淋巴结中Survivin、bcl-2、bax和bcl-X基因的表达
J Clin Oncol. 2003 Jan 15;21(2):306-12. doi: 10.1200/JCO.2003.08.066.
4
c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.葡萄膜黑色素瘤中c-myc、p53和Bcl-2的表达与临床结果
Br J Ophthalmol. 1999 Jan;83(1):110-4. doi: 10.1136/bjo.83.1.110.
5
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.高危皮肤恶性黑色素瘤及黑色素瘤转移灶中额外的c-myc癌基因拷贝。
Br J Cancer. 2001 Jan 5;84(1):72-9. doi: 10.1054/bjoc.2000.1535.
6
Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.bcl-2和c-myc反义寡核苷酸联合顺铂对人黑色素瘤异种移植瘤的抗肿瘤疗效:给药顺序的相关性
Clin Cancer Res. 2005 Mar 1;11(5):1990-8. doi: 10.1158/1078-0432.CCR-04-1284.
7
Different patterns of cell proliferation and death and oncogene expression in cutaneous malignant melanoma.皮肤恶性黑色素瘤中不同的细胞增殖、死亡模式及癌基因表达
J Cutan Pathol. 1998 May;25(5):244-51. doi: 10.1111/j.1600-0560.1998.tb01728.x.
8
bcl-2 protein expression in melanocytic neoplasms of the skin.皮肤黑素细胞肿瘤中bcl-2蛋白的表达
Mod Pathol. 1995 Feb;8(2):150-4.
9
Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.皮肤黑色素瘤中Bcl-2蛋白调控的免疫组织化学分析
Am J Pathol. 1995 Mar;146(3):643-50.
10
Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.细胞间黏附分子1(ICAM-1)和bcl-2在早期进展性恶性黑色素瘤中表达不同。
Am J Dermatopathol. 1995 Oct;17(5):429-38. doi: 10.1097/00000372-199510000-00001.

引用本文的文献

1
Synergistic inhibitory effects of the oxyresveratrol and dacarbazine combination against melanoma cells.氧化白藜芦醇与达卡巴嗪联合使用对黑色素瘤细胞的协同抑制作用。
Oncol Lett. 2021 Sep;22(3):667. doi: 10.3892/ol.2021.12928. Epub 2021 Jul 14.
2
Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.互作组分析基因表达谱揭示了白癜风皮肤病理学的潜在新的关键转录调控因子。
Genes Immun. 2016 Jan-Feb;17(1):30-45. doi: 10.1038/gene.2015.48. Epub 2015 Nov 12.
3
Born to be alive: a role for the BCL-2 family in melanoma tumor cell survival, apoptosis, and treatment.
生而存活:BCL-2家族在黑色素瘤肿瘤细胞存活、凋亡及治疗中的作用
Front Oncol. 2011 Oct 13;1(34). doi: 10.3389/fonc.2011.00034.
4
Reduced Apaf-1 expression in human cutaneous melanomas.
Br J Cancer. 2004 Sep 13;91(6):1089-95. doi: 10.1038/sj.bjc.6602092.
5
The role of Bcl-2 family members in the progression of cutaneous melanoma.Bcl-2家族成员在皮肤黑色素瘤进展中的作用。
Clin Exp Metastasis. 2003;20(6):531-9. doi: 10.1023/a:1025874502181.